skip to main content

    Updated Visitor Guidelines

 

MENU

 

Prostate Cancer

Radiation therapy outcomes better for African-American prostate cancer patients than Caucasian patients

While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new analysis indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy.

Subtype of Prostate Cancer Pinpointed by University of Michigan Researchers

Researchers led by the University of Michigan Rogel Cancer Center have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease.

Personal Growth After Cancer

Jeff Smith's prostate cancer diagnosis changed his perspective on life. After his treatment ended, he decided to leave behind all of those aspects of his life he didn’t love and start a new journey based on human connections.

Prostate Cancer and Hereditary Risk

Many of us are now aware that women with certain hereditary genetic mutations have an increased risk of breast cancer. What you might not know, though, is that some of those same genetic mutations -- and a handful of others -- are linked to aggressive prostate cancer in men.

Prostate Cancer Patient Documents His Treatment

Faced with 42 days of radiation therapy to treat his prostate cancer, Rodney Dan Marolf decided on the very first visit to make the daunting process a little more personal.

Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy

A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival outcomes.

Report: Black men with high-risk prostate cancer less likely to get aggressive treatment

Reuters reports on a study published in European Urology that shows that black men in America with medium- and high-risk prostate tumors are less likely to get aggressive treatment than white men are.

Pages